Galderma Group AG
GALD
Pozycja w akcjach
#457
Galderma Group AG operates as a dermatology company worldwide. The company... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Cena akcji
$224.81
Kapitalizacja rynkowa
$52.42B
Zmiana (1 dzień)
6.31%
Zmiana (1 rok)
31.28%
Kraj
CH
Handel Galderma Group AG (GALD)
Kategoria
Healthcare
Historia stopy dywidendy dla Galderma Group AG (GALD)
Stopa dywidendy (TTM) dla Galderma Group AG (symbol akcji: GALD) na dzień 2024-12-31 wynosi: 0.00%
Średnia stopa dywidendy z ostatnich 5 lat: 0.02%
Średnia stopa dywidendy z ostatnich 5 lat: 0.02%
Historia stopy dywidendy dla Galderma Group AG (GALD) od 2021 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
| Rok | Stopa dywidendy | Zmień |
|---|---|---|
| 2026 (TTM) | 0.19% | 137.50% |
| 2025 | 0.08% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
| Firma | Stopa dywidendy | Kraj |
|---|---|---|
| 1.63% |
DE
|
|
| 1.50% |
DE
|
|
| 3.18% |
JP
|
|
| 0.91% |
IN
|
|
| 0.43% |
CN
|
